Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

3-hydroxymorphinan is neurotrophic to dopaminergic neurons and is also neuroprotective against LPS-induced neurotoxicity.

Zhang W, Qin L, Wang T, Wei SJ, Gao HM, Liu J, Wilson B, Liu B, Zhang W, Kim HC, Hong JS.

FASEB J. 2005 Mar;19(3):395-7. Epub 2004 Dec 13.

PMID:
15596482
2.

Ion channels on microglia: therapeutic targets for neuroprotection.

Skaper SD.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):44-56. Review.

PMID:
21143139
3.

Novel anti-inflammatory therapy for Parkinson's disease.

Gao HM, Liu B, Zhang W, Hong JS.

Trends Pharmacol Sci. 2003 Aug;24(8):395-401. Review.

PMID:
12915048
4.

Selective oestrogen receptor modulators decrease the inflammatory response of glial cells.

Arevalo MA, Diz-Chaves Y, Santos-Galindo M, Bellini MJ, Garcia-Segura LM.

J Neuroendocrinol. 2012 Jan;24(1):183-90. doi: 10.1111/j.1365-2826.2011.02156.x. Review.

PMID:
21564348
5.

The role of glial cells in Parkinson's disease.

Vila M, Jackson-Lewis V, Guégan C, Wu DC, Teismann P, Choi DK, Tieu K, Przedborski S.

Curr Opin Neurol. 2001 Aug;14(4):483-9. Review.

PMID:
11470965
6.

Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.

'Episcopo FL, Tirolo C, Testa N, Caniglia S, Morale MC, Marchetti B.

Curr Aging Sci. 2013 Feb;6(1):45-55. Review.

PMID:
23895521
8.

Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons.

Kita T, Asanuma M, Miyazaki I, Takeshima M.

J Pharmacol Sci. 2014;124(3):313-9. Epub 2014 Mar 4. Review.

9.

Current disease modifying approaches to treat Parkinson's disease.

Lindholm D, Mäkelä J, Di Liberto V, Mudò G, Belluardo N, Eriksson O, Saarma M.

Cell Mol Life Sci. 2016 Apr;73(7):1365-79. doi: 10.1007/s00018-015-2101-1. Epub 2015 Nov 30. Review.

PMID:
26616211
10.

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease.

Labandeira-Garcia JL, Rodríguez-Perez AI, Villar-Cheda B, Borrajo A, Dominguez-Meijide A, Guerra MJ.

Neuroscientist. 2015 Dec;21(6):616-29. doi: 10.1177/1073858414554954. Epub 2014 Oct 16. Review.

PMID:
25323761
12.

The lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.

Dutta G, Zhang P, Liu B.

Fundam Clin Pharmacol. 2008 Oct;22(5):453-64. doi: 10.1111/j.1472-8206.2008.00616.x. Epub 2008 Aug 15. Review.

13.

Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice.

Machado V, Zöller T, Attaai A, Spittau B.

Int J Mol Sci. 2016 Jan 26;17(2). pii: E151. doi: 10.3390/ijms17020151. Review.

14.

Neuropsychopharmacological understanding for therapeutic application of morphinans.

Shin EJ, Hong JS, Kim HC.

Arch Pharm Res. 2010 Oct;33(10):1575-87. doi: 10.1007/s12272-010-1009-4. Epub 2010 Oct 30. Review.

15.

Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation.

Zhang F, Liu J, Shi JS.

Eur J Pharmacol. 2010 Jun 25;636(1-3):1-7. doi: 10.1016/j.ejphar.2010.03.043. Epub 2010 Mar 31. Review.

PMID:
20361959
16.

Preactive multiple sclerosis lesions offer novel clues for neuroprotective therapeutic strategies.

van Noort JM, van den Elsen PJ, van Horssen J, Geurts JJ, van der Valk P, Amor S.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):68-81. Review.

PMID:
21143143
17.

Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator.

Skaper SD, Facci L, Giusti P.

Mol Neurobiol. 2013 Oct;48(2):340-52. doi: 10.1007/s12035-013-8487-6. Epub 2013 Jun 28. Review.

PMID:
23813098
18.

[Neuroprotective effect of baicalein in patients with Parkinson's disease].

Yu X, He G, Du G.

Zhongguo Zhong Yao Za Zhi. 2012 Feb;37(4):421-5. Review. Chinese.

PMID:
22667137
19.

Inflammation as a causative factor in the aetiology of Parkinson's disease.

Whitton PS.

Br J Pharmacol. 2007 Apr;150(8):963-76. Epub 2007 Mar 5. Review.

20.

Astrocytes and microglia: responses to neuropathological conditions.

Singh S, Swarnkar S, Goswami P, Nath C.

Int J Neurosci. 2011 Nov;121(11):589-97. doi: 10.3109/00207454.2011.598981. Epub 2011 Aug 9. Review.

PMID:
21827229

Supplemental Content

Support Center